These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12478618)

  • 1. Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies.
    Rosenbluth J; Moon D
    J Neurosci Res; 2003 Jan; 71(1):104-9. PubMed ID: 12478618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
    Rosenbluth J; Schiff R; Liang WL; Dou W
    J Neurocytol; 2003 Mar; 32(3):265-76. PubMed ID: 14724389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord dysmyelination caused by an antiproteolipid protein IgM antibody: implications for the mechanism of central nervous system myelin formation.
    Rosenbluth J; Schiff R
    J Neurosci Res; 2009 Mar; 87(4):956-63. PubMed ID: 18951490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord dysmyelination induced in vivo by IgM antibodies to three different myelin glycolipids.
    Rosenbluth J; Liang WL; Schiff R; Dou WK
    Glia; 1997 Jan; 19(1):58-66. PubMed ID: 8989568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated CNS demyelination: focal spinal cord lesions induced by implantation of an IgM anti-galactocerebroside-secreting hybridoma.
    Rosenbluth J; Schiff R; Liang WL; Dou WK; Moon D
    J Neurocytol; 1999; 28(4-5):397-416. PubMed ID: 10739579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cells depleted of galactocerebroside express myelin-associated glycoprotein and initiate but do not continue the process of myelination.
    Owens GC; Bunge RP
    Glia; 1990; 3(2):118-24. PubMed ID: 1692007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CNS myelin development in vivo by implantation of anti-GalC hybridoma cells.
    Rosenbluth J; Liu Z; Guo D; Schiff R
    J Neurocytol; 1994 Nov; 23(11):699-707. PubMed ID: 7861184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paranodal structural abnormalities in rat CNS myelin developing in vivo in the presence of implanted O1 hybridoma cells.
    Rosenbluth J; Liang WL; Liu Z; Guo D; Schiff R
    J Neurocytol; 1995 Nov; 24(11):818-24. PubMed ID: 8576711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regeneration of brainstem-spinal axons after lesion and immunological disruption of myelin in adult rat.
    Dyer JK; Bourque JA; Steeves JD
    Exp Neurol; 1998 Nov; 154(1):12-22. PubMed ID: 9875263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded CNS myelin sheaths formed in situ in the presence of an IgM antigalactocerebroside-producing hybridoma.
    Rosenbluth J; Liang WL; Liu Z; Guo D; Schiff R
    J Neurosci; 1996 Apr; 16(8):2635-41. PubMed ID: 8786439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to glycolipids and cholera toxin B subunit do not initiate Ca++ signaling in rat Schwann cells.
    Skoff AM; Benjamins JA
    J Peripher Nerv Syst; 1998; 3(1):19-27. PubMed ID: 10959234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein.
    Tatum AH
    Ann Neurol; 1993 May; 33(5):502-6. PubMed ID: 7684583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin-associated glycoprotein and galactosylcerebroside expression in Schwann cells during myelination.
    Päiväläinen S; Heape AM
    Mol Cell Neurosci; 2007 Jul; 35(3):436-46. PubMed ID: 17513122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of in vitro peripheral myelin formation by monoclonal anti-galactocerebroside.
    Ranscht B; Wood PM; Bunge RP
    J Neurosci; 1987 Sep; 7(9):2936-47. PubMed ID: 3625279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypermyelination in a case of peripheral neuropathy with benign IgM monoclonal gammopathy].
    Vital C; Pautrizel B; Lagueny A; Vital A; Bergouignan FX; David B; Loiseau P
    Rev Neurol (Paris); 1985; 141(11):729-34. PubMed ID: 3003872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated demyelination--immunopathological basis for electrophysiological changes.
    Saida T; Saida K
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():56-69. PubMed ID: 6962042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dorsal root ganglion neurons induce transdifferentiation of mesenchymal stem cells along a Schwann cell lineage.
    Yang J; Lou Q; Huang R; Shen L; Chen Z
    Neurosci Lett; 2008 Nov; 445(3):246-51. PubMed ID: 18804147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant human IgM promotes myelin repair after a single, very low dose.
    Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
    J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ; Tator CH
    Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
    Sawant-Mane S; Clark MB; Koski CL
    Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.